台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    118.0
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    49
  • 產業
    上櫃 文化創意指數
  • 106人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
智基 (6294)籌碼相關-兆豐-台中港 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

兆豐-台中港 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/04/221115.0000.00116.0011140.88%
2024/04/192115.7500.00116.0021131.77%
2024/04/1600.004114.50114.00-4111-3.60%
2024/04/021122.0000.00123.501701.41%
2024/04/013122.6700.00123.003694.31%
2024/03/280122.0000.00122.500670.01%
2024/03/2700.001121.50122.00-166-1.51%
2024/03/1300.001117.00116.50-139-2.55%
2024/03/122116.251117.50117.001382.57%
2024/03/1100.001114.50114.50-136-2.77%
2024/03/081113.5000.00113.501342.87%
2024/03/0700.001114.00114.00-134-2.91%
2024/01/301110.5000.00110.001313.21%
2024/01/261110.5000.00110.501303.27%
2023/09/1800.000114.00115.00026-0.11%
2023/08/2800.000.1112.00110.50-0.130-0.28%
2023/07/2800.007114.50115.00-732-21.63%
2023/06/131108.5000.00108.001541.83%
2023/05/312108.0000.00108.002553.59%
2023/05/260109.5000.00109.000560.05%
2023/05/120108.0000.00106.500550.01%
2023/05/051108.0000.00109.001531.89%
2023/05/030109.0000.00108.500520.01%
2023/04/261108.0000.00108.501531.89%
2023/04/170111.0000.00109.500510.01%
2023/04/140111.005111.20111.00-550-9.93%
2023/04/131118.5000.00119.501472.09%
2023/04/123120.8300.00119.003427.07%
2023/04/101120.5000.00120.501392.56%
2023/03/290.1117.5000.00117.000.1350.24%
2023/03/030111.5000.00111.000360.01%
2022/12/2600.004105.38107.00-440-10.00%
2022/12/2300.002103.00103.00-238-5.16%
2022/12/2200.005103.00103.00-538-12.90%
2022/12/2100.005102.90103.00-538-12.93%
2022/12/2000.0011102.64102.50-1138-28.38%
2022/12/1600.001103.50103.50-138-2.59%
2022/12/0710101.0500.00100.50103627.24%
2022/12/066101.7500.00102.0063417.62%
2022/12/0512101.8300.00101.50123236.87%
2022/05/16999.6700.0098.7094121.74%
2022/05/121115.0000.00109.001332.98%
2022/04/111135.5000.00134.501224.37%
2022/03/021125.0000.00126.001224.42%
2022/01/101126.0000.00125.501234.29%
2021/11/020.8128.0100.00126.000.8322.34%
2021/10/1300.001125.50125.00-140-2.47%
2021/10/121134.0000.00132.501372.69%
2021/09/3000.000.1142.00141.00-0.134-0.30%
2021/09/1600.000.1143.53143.50-0.133-0.17%
2021/08/300146.0000.00147.000360.07%
2021/08/1300.000.1150.50150.50-0.136-0.25%
2021/08/120150.0000.00150.500350.07%
2021/08/040141.0000.00144.000360.07%
2021/07/140.1151.5000.00150.500.1320.31%
2021/07/130150.5000.00150.500320.15%
2021/07/050153.0000.00153.500390.06%
2021/06/071146.0000.00146.501452.20%
2021/05/131140.0000.00141.501452.20%
2021/04/2100.000.1146.50146.50-0.137-0.16%
2021/04/2000.000.1147.00147.50-0.137-0.13%
2021/04/0900.001146.00145.50-135-2.84%
2021/03/2400.001140.50140.50-127-3.64%
2021/03/221142.0000.00140.501253.87%
2021/03/155133.0000.00133.0052619.22%
2020/12/0300.002128.00127.00-232-6.18%
2020/12/022123.0000.00124.002306.48%
2020/10/1900.001111.50111.50-134-2.91%
2020/06/151111.0000.00111.501531.86%
2020/03/1700.00190.5090.90-135-2.84%
2020/01/1600.001102.00102.00-122-4.38%
2019/11/1100.001102.00102.00-121-4.74%
2019/10/281102.0000.00102.001214.62%
2019/06/2400.000.1109.00110.00-0.141-0.24%
2019/05/0200.001109.50109.50-140-2.48%
2019/04/021107.5000.00107.501342.92%
2019/03/111108.5000.00108.501253.92%
2018/07/3100.000118.00113.50073-0.01%
2018/07/200.1126.5000.00126.500.1840.12%
2018/06/1500.000124.50124.500108-0.02%
2018/05/3100.001124.00124.00-1121-0.82%
2018/05/071131.0000.00131.5011240.80%
2018/04/191122.0000.00123.0011620.62%
2018/03/1900.001128.00127.50-1176-0.57%
2018/03/061120.5000.00119.5011760.57%
2018/02/2700.001.3117.00117.00-1.3172-0.73%
2018/02/0100.001120.00120.00-1163-0.61%
2018/01/2400.001124.00124.00-1158-0.63%
2018/01/221122.5000.00122.5011520.66%
2018/01/192125.501123.50124.0011480.67%
2018/01/171118.502.1120.26121.50-1.1129-0.81%
2018/01/161118.0000.00116.0011180.84%
2018/01/1500.000.1117.00118.00-0.1114-0.10%
2018/01/0400.000.4112.00112.00-0.498-0.39%
2018/01/0300.002109.50109.50-296-2.06%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音